Real Chemistry Acquires Greater Than One

Real Chemistry Acquires Avant Healthcare

February 6, 2024

Healthcare Services

Real Chemistry has acquired Avant Healthcare, a Carmel, Indiana-based medical communications firm, to expand its medical education, medical affairs and HCP communications capabilities. The acquisition, which closed Feb. 1, 2024 for undisclosed terms, more than doubles Real Chemistry’s medical team and enhances its scientific, data-driven medical communications offering for life sciences clients.

Real Chemistry Acquires Spring & Bond

October 15, 2025

Marketing & Advertising

Real Chemistry has acquired Spring & Bond, a New York–based digital media agency focused on omnichannel, data-driven media for the healthcare sector. The deal strengthens Real Chemistry's media and omnichannel capabilities; Spring & Bond's founder Elizabeth Beringer will continue to lead the team reporting to Kevin Johnson.

Real Chemistry Acquires conversationHEALTH

April 5, 2022

Healthcare Services

Real Chemistry, a San Francisco-based health innovation company, has acquired conversationHEALTH, a HIPAA-compliant conversational AI SaaS platform for the health care and life sciences industry. The acquisition expands Real Chemistry's Data and Artificial Intelligence Solutions capabilities by adding conversational AI, medically-trained NLU and intelligent agents for scientific communications, medical affairs, clinical trials and commercial operations.

Real Chemistry Acquires TI Health and Integrates It into Swoop

March 1, 2023

Data & Analytics

Real Chemistry has acquired TI Health, a data-driven HCP engagement and predictive analytics company, and will integrate TI Health into Swoop to create a unified HCP and DTC system of engagement for healthcare marketers. TI Health, previously a portfolio company of Capital Dynamics, Star Mountain Capital, and Halyard Capital, will bring its Affiniti platform and HCP targeting capabilities to Swoop’s privacy-safe patient audiences to enable coordinated omnichannel campaigns.

Catalent Acquires Bettera Brands from Highlander Partners for $1 Billion

August 30, 2021

Food & Beverage

Catalent, Inc. agreed to acquire Bettera Holdings, LLC (Bettera Brands) from Highlander Partners for $1 billion. The acquisition expands Catalent's consumer health and nutraceutical manufacturing capabilities—adding Bettera's gummy, soft chew, and lozenge production capacity and approximately 500 employees across four U.S. facilities.

Inhance Technologies Acquires Advance Research Chemicals

October 14, 2021

Manufacturing

Inhance Technologies, a portfolio company of Aurora Capital Partners, has completed the acquisition of Advance Research Chemicals (ARC), a specialty chemicals and materials producer with production facilities in the United States and Mexico. The add-on expands Inhance's capabilities in high-purity specialty chemicals, custom synthesis and private-label manufacturing to serve end markets including medical batteries, semiconductors, 3D printing and pharmaceuticals.